Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2012 Mar 14;2012(3):CD008328.
doi: 10.1002/14651858.CD008328.pub2.

Airway clearance techniques for chronic obstructive pulmonary disease

Affiliations
Meta-Analysis

Airway clearance techniques for chronic obstructive pulmonary disease

Christian R Osadnik et al. Cochrane Database Syst Rev. .

Abstract

Background: Cough and sputum production are common in chronic obstructive pulmonary disease (COPD) and are associated with adverse clinical outcomes. Airway clearance techniques (ACTs) aim to remove sputum from the lungs, however evidence of their efficacy during acute exacerbations of COPD (AECOPD) or stable disease is unclear.

Objectives: To assess the safety and efficacy of ACTs for individuals with AECOPD and stable COPD.

Search methods: We searched the Cochrane Airways Group Specialised Register of trials from inception to October 2011, and PEDro in October 2009.

Selection criteria: We included randomised parallel trials and randomised cross-over trials which compared an ACT to no treatment, cough or sham ACT in participants with investigator-defined COPD, emphysema or chronic bronchitis.

Data collection and analysis: Two review authors independently conducted data extraction and assessed the risk of bias. We analysed data from studies of AECOPD separately from stable COPD, and classified the effects of ACTs as 'immediate' (less than 24 hours), 'short-term' (24 hours to eight weeks) or 'long-term' (greater than eight weeks). One subgroup analysis compared the effects of ACTs that use positive expiratory pressure (PEP) to those that do not.

Main results: Twenty-eight studies on 907 participants were included in the review. Study sample size was generally small (range 5 to 96 people) and overall quality was generally poor due to inadequate blinding and allocation procedures. Meta-analyses were limited by heterogeneity of outcome measurement and inadequate reporting of data.In people experiencing AECOPD, ACT use was associated with small but significant short-term reductions in the need for increased ventilatory assistance (odds ratio (OR) 0.21, 95% confidence interval (CI) 0.05 to 0.85; data from four studies on 171 people), the duration of ventilatory assistance (mean difference (MD) -2.05 days, 95% CI -2.60 to -1.51; mean duration for control groups seven days; data from two studies on 54 people) and hospital length of stay (MD -0.75 days, 95% CI -1.38 to -0.11; mean duration for control groups nine days; one study on 35 people). Data from a limited number of studies revealed no significant long-term benefits of ACTs on the number of exacerbations or hospitalisations, nor any short-term beneficial effect on health-related quality of life (HRQoL) as measured by the St. George's Respiratory Questionnaire (SGRQ) total score (MD -2.30, 95% CI -11.80 to 7.20; one study on 59 people).In people with stable COPD, data from single studies revealed no significant short-term benefit of ACTs on the number of people with exacerbations (OR 3.21, 95% CI 0.12 to 85.20; one study on 30 people), significant short-term improvements in HRQoL as measured by the SGRQ total score (MD -6.10, 95% CI -8.93 to -3.27; one study on 15 people) and a reduced long-term need for respiratory-related hospitalisation (OR 0.27, 95% CI 0.08 to 0.95; one study on 35 participants).The magnitude of effect of PEP-based ACTs on the need for increased ventilatory assistance and hospital length of stay was greater than for non-PEP ACTs, however we found no statistically significant subgroup differences. There was one report of vomiting during treatment with postural drainage and head-down tilt.

Authors' conclusions: Evidence from this review indicates that airway clearance techniques are safe for individuals with COPD and confer small beneficial effects on some clinical outcomes. Consideration may be given to the use of airway clearance techniques for patients with COPD in both acute and stable disease, however current studies suggest that the benefits achieved may be small.

PubMed Disclaimer

Conflict of interest statement

CO, CM and AH are conducting a study which may be included in future updates of this review.

Figures

1
1
Study flow diagram.
2
2
'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
3
3
'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
4
4
Forest plot of comparison: 1 Acute COPD: ACTs vs no ACTs (control), outcome: 1.5 Need for increased ventilatory assistance (invasive or non‐invasive).
5
5
Forest plot of comparison: 1 Acute COPD: ACTs vs no ACTs (control), outcome: 1.6 Duration of ventilatory assistance (days).
6
6
Forest plot of comparison: 1 Acute COPD: ACTs vs no ACTs (control), outcome: 1.8 Length of hospital stay (days).
1.1
1.1. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 1 Number of AECOPDs (long‐term).
1.2
1.2. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 2 Number of AECOPDs (long‐term).
1.3
1.3. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 3 Need for respiratory hospital admission (long‐term).
1.4
1.4. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 4 Need for respiratory hospital admission (long‐term).
1.5
1.5. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 5 Need for increased ventilatory assistance (invasive or non‐invasive).
1.6
1.6. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 6 Duration of ventilatory assistance (days).
1.7
1.7. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 7 Length of ICU stay (days).
1.8
1.8. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 8 Length of hospital stay (days).
1.9
1.9. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 9 QOL ‐ SGRQ total (short‐term).
1.10
1.10. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 10 FEV1 (L) (short‐term).
1.11
1.11. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 11 VC (L) (short‐term).
1.12
1.12. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 12 FEV1/FVC (%) (short‐term).
1.13
1.13. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 13 Gas exchange: pH (short‐term).
1.14
1.14. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 14 Gas exchange: PaO2 (mmHg) (short‐term).
1.15
1.15. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 15 Gas exchange: PaCO2 (mmHg) (short‐term).
1.16
1.16. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 16 Gas exchange: SpO2 (%) (short‐term).
1.17
1.17. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 17 Breathlessness ‐ Borg scale (short‐term).
1.18
1.18. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 18 Sputum weight, g (immediate).
1.19
1.19. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 19 Sputum volume, ml (immediate).
1.20
1.20. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 20 Sputum volume, ml (24/24) (short‐term).
1.21
1.21. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 21 Mortality (short‐term).
1.22
1.22. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 22 Mortality (long‐term).
1.23
1.23. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 23 Participant withdrawal (immediate).
1.24
1.24. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 24 Participant withdrawal (short‐term).
1.25
1.25. Analysis
Comparison 1 Acute COPD: ACTs vs no ACTs (control), Outcome 25 Participant withdrawal (long‐term).
2.1
2.1. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 1 Number of AECOPDs (short‐term).
2.2
2.2. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 2 Need for respiratory hospital admission (long‐term).
2.3
2.3. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 3 Total number of days hospitalised (long‐term).
2.4
2.4. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 4 QOL ‐ SGRQ total (short‐term).
2.5
2.5. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 5 FEV1 (L) (immediate).
2.6
2.6. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 6 FEV1 (L) (short‐term).
2.7
2.7. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 7 VC (L) (immediate).
2.8
2.8. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 8 VC (L) (short‐term).
2.9
2.9. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 9 Gas exchange: PaO2 (mmHg) (short‐term).
2.10
2.10. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 10 Gas exchange: PaCO2 (mmHg) (short‐term).
2.11
2.11. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 11 Gas exchange: SpO2 (%) (immediate).
2.12
2.12. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 12 Breathlessness, Borg scale (immediate).
2.13
2.13. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 13 Sputum weight, g (immediate).
2.14
2.14. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 14 Sputum volume, ml (immediate).
2.15
2.15. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 15 Mucociliary clearance, scintigraphy (% retention).
2.16
2.16. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 16 Exercise tolerance, 6MWD (m) (short‐term).
2.17
2.17. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 17 Exercise tolerance, 12MWD (m) (long‐term).
2.18
2.18. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 18 Need for antibiotics (short‐term).
2.19
2.19. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 19 Need for antibiotics (long‐term).
2.20
2.20. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 20 Participant withdrawal (short‐term).
2.21
2.21. Analysis
Comparison 2 Stable COPD: ACTs vs no ACTs (control), Outcome 21 Participant withdrawal (long‐term).

Update of

References

References to studies included in this review

Anthonisen 1964 {published data only}
    1. Anthonisen P, Riis P, Sogaard‐Andersen T. The value of lung physiotherapy in the treatment of acute exacerbations in chronic bronchitis. Acta Medica Scandinavica 1964; Vol. 175, issue 6:715‐9. - PubMed
Bellone 2002 {published data only}
    1. Bellone A, Spagnolatti L, Massobrio M, Barbieri A, Jori E, Argentini I, et al. Chest physical therapy in COPD patients with acute hypercapnic respiratory failure (AHRF) who will require non invasive ventilation (NIV). European Respiratory Journal 2000; Vol. 16, issue Suppl 31:15s.
    1. Bellone A, Spagnolatti L, Massobrio M, Bellei E, Vinciguerra R, Barbieri A, et al. Short‐term effects of expiration under positive pressure in patients with acute exacerbation of chronic obstructive pulmonary disease and mild acidosis requiring non‐invasive positive pressure ventilation. Intensive Care Medicine 2002; Vol. 28, issue 5:581‐5. - PubMed
Brown 1987 {published data only}
    1. Brown PM, Manfreda J, McCarthy DS, Macdonald S. The effect of mechanical vibration in patients with acute exacerbations of chronic obstructive pulmonary disease. Physiotherapy Canada 1987; Vol. 39, issue 6:371‐4.
Cegla 1997 {published data only}
    1. Cegla UH, Bautz M, Frode G, Werner T. (Physical therapy in patients with COPD and tracheobronchial instability ‐‐ comparison of 2 oscillating PEP systems (RC‐Cornet, VRP1 Desitin). Results of a randomized prospective study of 90 patients) [German]. Pneumologie 1997; Vol. 51, issue 2:129‐36. - PubMed
Cegla 2001 {published data only}
    1. Cegla UH. Effects of salbutamol; ipratropium bromide and additive physiotherapy with the RC‐cornet® on airway‐conductance in COPD‐patients. American Journal of Respiratory and Critical Care Medicine 2000; Vol. 161, issue Suppl 3:A574.
    1. Cegla UH, Jost HJ, Harten A, Gross S, Weber T. Sequential therapy by salbutamol, ipratropium bromide and physiotherapy in COPD patients. European Respiratory Journal 2000; Vol. 16, issue Suppl 31:46s.
    1. Cegla UH, Jost JH, Harten A, Weber T. RC‐Cornet improves the bronchodilating effect of ipratropium bromide (Atrovent) inhalation in COPD‐patients. Pneumologie 2001; Vol. 55, issue 10:465‐9. - PubMed
Cegla 2002 {published data only}
    1. Cegla UH, Jost HJ, Harten A, Weber T, Wissmann S. Course of severe COPD with and without physiotherapy with the RC‐Cornet [German]. Pneumologie 2002; Vol. 56, issue 7:418‐24. - PubMed
Christensen 1990 {published data only}
    1. Christensen HR, Simonsen K, Lange P, Clementsen P, Kampmann JP, Viskum K, et al. PEEP‐masks in patients with severe obstructive pulmonary disease: a negative report. European Respiratory Journal 1990; Vol. 3, issue 3:267‐72. - PubMed
Christensen 1991 {published data only}
    1. Christensen EF, Dahl R. Treatment of chronic bronchitis with terbutaline inhaled from a cone spacer with and without positive expiratory pressure. Lung 1991; Vol. 169, issue 6:325‐33. - PubMed
Christensen 1991a {published data only}
    1. Christensen EF, Norregaard O, Dahl R. Nebulized terbutaline and positive expiratory pressure in chronic obstructive pulmonary disease. Pneumologie 1991; Vol. 45, issue 3:105‐9. - PubMed
Haidl 2002 {published data only}
    1. Haidl P, Rickert G, Cegla UH, Kohler D. Influence of an oscillating physiotherapy device (RC‐Cornet trade mark) on the regional distribution of the pulmonary aerosol deposition in patients with COPD. Pneumologie 2002; Vol. 56, issue 8:498‐502. - PubMed
Hasani 1995 {published data only}
    1. Hasani A, Toms N, Agnew JE, Pavia D, Clarke SW. Regional mucus clearance following cough and forced expiration technique in patients with asthma, chronic bronchitis and bronchiectasis [abstract]. European Respiratory Journal. Supplement. 1995; Vol. 8, issue Suppl 19:297S.
Inal‐Ince 2004 {published and unpublished data}
    1. Inal‐Ince D, Savci S, Topeli A, Arikan H. Active cycle of breathing techniques in non‐invasive ventilation for acute hypercapnic respiratory failure. Australian Journal of Physiotherapy 2004; Vol. 50, issue 2:67‐73. - PubMed
Kodric 2009 {published and unpublished data}
    1. Garuti G, Confalonieri M, Cacciatori B, Colomban M, Lusardi M. The effectiveness of a bronchial drainage technique (ELTGOL) in COPD exacerbations [Abstract]. European Respiratory Journal 2005; Vol. 26, issue Suppl 49:Abstract No. 3257.
    1. Kodric M, Garuti G, Colomban M, Russi B, Della Porta R, Lusardi M, et al. The effectiveness of a bronchial drainage technique (ELTGOL) in COPD exacerbations [Abstract]. European Respiratory Society Annual Congress, Berlin, Germany, October 4‐8 2008:[P3336].
    1. Kodric M, Garuti G, Colomban M, Russi B, Porta RD, Lusardi M, et al. The effectiveness of a bronchial drainage technique (ELTGOL) in COPD exacerbations. Respirology 2009; Vol. 14, issue 3:424‐8. - PubMed
Martins 2006 {published and unpublished data}
    1. Martins JA, Parreira VF, Dornelas A, Salim R, Tomich G, Lara R. Measurements of swallowing pulmonary secretions in the stomach area through scintigraphy after ELTGOL [Abstract]. European Respiratory Journal 2006; Vol. 28, issue Suppl 50:731s [P4193].
Martins 2007 {published and unpublished data}
    1. Martins JA, Lara R, Assis RS, Dornelas AF, Parreira VF. Effect of ELTGOL on removal of lung secretion in patients with COPD [Abstract]. European Respiratory Journal 2007; Vol. 30, issue Suppl 51:223s [E1363].
    1. Martins JA, Tomich GM, Dornelas AD, Salim RA, Lara R, Parreira VF. The effects of ELTGOL on mucociliary clearance in patients with COPD [Abstract]. European Respiratory Journal 2006; Vol. 28, issue Suppl 50:731s [P4194].
May 1979 {published data only}
    1. May DB, Munt PW. Physiologic effects of chest percussion and postural drainage in patients with stable chronic bronchitis. Chest 1979; Vol. 75, issue 1:29‐32. - PubMed
Morsch 2008 {published data only}
    1. Morsch AL, Amorim MM, Barbieri A, Santoro l, Fernandes ALG. Influence of oscillating positive expiratory pressure and the forced expiratory technique on sputum cell counts and quantity of induced sputum in patients with asthma or chronic obstructive pulmonary disease. Jornal Brasileiro de Pneumologia 2008; Vol. 34, issue 12:1026‐32. - PubMed
Newton 1978 {published data only}
    1. Newton DA, Bevans HG. Physiotherapy and intermittent positive‐pressure ventilation of chronic bronchitis. British Medical Journal 1978; Vol. 2, issue 6151:1525‐8. - PMC - PubMed
Newton 1978a {published data only}
    1. Newton DA, Stephenson A. Effect of physiotherapy on pulmonary function. A laboratory study. Lancet 1978; Vol. 2, issue 8083:228‐9. - PubMed
Oldenburg 1979 {published data only}
    1. Oldenburg FA, Dolovich MB, Montgomery JM, Newhouse MT. Effects of postural drainage, exercise, and cough on mucus clearance in chronic bronchitis. American Review Respiratory Diseases 1979; Vol. 120, issue 4:739‐45. - PubMed
Pavia 1976 {published data only}
    1. Pavia D, Thomson ML, Phillipakos D. A preliminary study of the effect of a vibrating pad on bronchial clearance. American Review of Respiratory Disease 1976; Vol. 113, issue 1:92‐6. - PubMed
Rasmussen 2001 {published data only}
    1. Rasmussen TR, Juul I. Positive expiratory pressure (PEP) and sputum elimination. European Respiratory Journal 2001; Vol. 18, issue Suppl 33:301s.
Rivington‐Law 1984 {published data only}
    1. Rivington‐Law BA, Epstein SW, Thompson GL, Pulm R, Corey PN. Effect of chest wall vibrations on pulmonary function in chronic bronchitis. Chest 1984; Vol. 85, issue 3:378‐81. - PubMed
van Hengstum 1988 {published data only}
    1. Hengstum M, Festen J, Beurskens C, Hankel M, Beekman F, Corstens F. Effect of positive expiratory pressure mask physiotherapy (PEP) versus forced expiration technique (FET/PD) on regional lung clearance in chronic bronchitics. European Respiratory Journal 1991; Vol. 4, issue 6:651‐4. - PubMed
    1. Hengstum M, Festen J, Beurskens C, Hankel M, Broek W, Buijs W, et al. The effect of positive expiratory pressure versus forced expiration technique on tracheobronchial clearance in chronic bronchitics. Scandinavian Journal of Gastroenterology ‐ Supplement 1988; Vol. 143:114‐8. - PubMed
Vargas 2005 {published data only}
    1. Vargas F, Bui HN, Boyer A, Salmi LR, Gbikpi‐Benissan G, Guenard H, et al. Intrapulmonary percussive ventilation in acute exacerbations of COPD patients with mild respiratory acidosis: a randomized controlled trial [with consumer summary]. Critical Care 2005; Vol. 9, issue 4:R382‐9. - PMC - PubMed
    1. Vargas F, Gruson D, Bui HN, Herbland A, Gbikpi‐Benissan G, Guenard H, et al. Intrapulmonary percussive ventilation in exacerbation of chronic obstructive pulmonary disease [abstract]. American Thoracic Society 99th International Conference 2003:A108 Poster C68.
Weiner 1996 {published data only}
    1. Weiner P, Zamir D, Waizman J, Weiner M. Physiotherapy in chronic obstructive pulmonary disease: oscillatory breathing with flutter VRP1. Harefuah 1996; Vol. 131, issue 1‐2:14‐7, 71. - PubMed
Wolkove 2002 {published data only}
    1. Wolkove N, Kamel H, Rotaple M, Baltzan MA, Jr. Use of a mucus clearance device enhances the bronchodilator response in patients with stable COPD. Chest 2002; Vol. 121, issue 3:702‐7. - PubMed
Wolkove 2004 {published data only}
    1. Baltzan MA, Kamel H, Rotaple M, Wolkove N. Daily use of mucus clearance device improves the disability and quality of life in patients with stable chronic obstructive pulmonary disease (COPD) [Abstract]. Chest 2002:P286.
    1. Wolkove N, Baltzan Jr MA, Kamel H, Rotaple M. A randomized trial to evaluate the sustained efficacy of a mucus clearance device in ambulatory patients with chronic obstructive pulmonary disease. Canadian Respiratory Journal 2004; Vol. 11, issue 8:567‐72. - PubMed

References to studies excluded from this review

Ambrosino 1981 {published data only}
    1. Ambrosino N, Paggiaro PL, Macchi M, Filieri M, Toma G, Lombardi FA, et al. A study of short‐term effect of rehabilitative therapy in chronic obstructive pulmonary disease. Respiration 1981; Vol. 41, issue 1:40‐4. - PubMed
Ambrosino 1995 {published data only}
    1. Ambrosino N, Callegari G, Galloni C, Brega S, Pinna G. Clinical evaluation of oscillating positive expiratory pressure for enhancing expectoration in diseases other than cystic fibrosis. Monaldi Archives for Chest Disease 1995; Vol. 50, issue 4:269‐75. - PubMed
Anonymous 2001 {published data only}
    1. Anonymous. COPD: anticholinergics + physical therapy. Preserving the quality of life. MMW Fortschritte der Medizin 2001; Vol. 143, issue 15:53‐4. - PubMed
Antonaglia 2006 {published data only}
    1. Antonaglia V, Lucangelo U, Zin WA, Peratoner A, Simoni L, Capitanio G, et al. Intrapulmonary percussive ventilation improves the outcome of patients with acute exacerbation of chronic obstructive pulmonary disease using a helmet. Critical Care Medicine 2006; Vol. 34, issue 12:2940‐5. - PubMed
Babu 2010 {published data only}
    1. Babu AS, Noone MS, Haneef M, Samuel P. The effects of 'on‐call/out of hours' physical therapy in acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Clinical Rehabilitation 2010;24(9):802‐9. - PubMed
Badr 2002 {published data only}
    1. Badr C, Elkins MR, Ellis ER. The effect of body position on maximal expiratory pressure and flow. Australian Journal of Physiotherapy 2002; Vol. 48, issue 2:95‐102. - PubMed
Barat 1975 {published data only}
    1. Barat G, Asuero MS. Positive end‐expiratory pressure. Effect on arterial oxygenation during respiratory failure in chronic obstructive airway disease. Anaesthesia 1975; Vol. 30, issue 2:183‐9. - PubMed
Bateman 1981 {published data only}
    1. Bateman JR, Newman SP, Daunt KM, Sheahan NF, Pavia D, Clarke SW. Is cough as effective as chest physiotherapy in the removal of excessive tracheobronchial secretions?. Thorax 1981; Vol. 36, issue 9:683‐7. - PMC - PubMed
Bellone 1997 {published data only}
    1. Bellone A, Guzzi L, Ramponi A, Sanniti A, Lazzeri M, Brivio A. Short‐term effects of oscillating positive expiratory pressure vs expiration with the glottis open in lateral posture on oxygen saturation and sputum recovery in patients with chronic bronchitis. European Respiratory Journal. Supplement 1997; Vol. 10, issue Suppl 25:73S.
Bellone 2000a {published data only}
    1. Bellone A, Lascioli R, Raschi S, Guzzi L, Adone R. Chest physical therapy in patients with acute exacerbation of chronic bronchitis: effectiveness of three methods. Archives of Physical Medicine & Rehabilitation 2000; Vol. 81, issue 5:558‐60. - PubMed
Boye 1994 {published data only}
    1. Boye NP, Udjus E, Ottersen I, Refsum HE. Physiotherapy in chronic obstructive pulmonary disease with and without mask training. Tidsskrift for Den Norske Laegeforening 1994; Vol. 114, issue 22:2606‐8. - PubMed
Butcher 2007 {published data only}
    1. Butcher SJ, Pasiorowski MP, Jones RL. Effects of changes in lung volume on oscillatory flow rate during high‐frequency chest wall oscillation. Canadian Respiratory Journal 2007; Vol. 14, issue 3:153‐8. - PMC - PubMed
Cai 2003 {published data only}
    1. Cai H. Rehabilitation effect of combination of respiration exercise, Jinshuibao capsule and external application in stable stage of chronic obstructive pulmonary diseases. Zhonghua Linchuang Kangfu Zazhi 2003; Vol. 7, issue 5:877.
Campbell 1955 {published data only}
    1. Campbell EJ, Friend J. Action of breathing exercises in pulmonary emphysema. Lancet 1955; Vol. 265, issue 6859:325‐9. - PubMed
Cegla 1993 {published data only}
    1. Cegla UH, Retzow A. Physical therapy with VRP1 in chronic obstructive respiratory tract diseases‐‐results of a multicenter comparative study. Pneumologie 1993; Vol. 47, issue 11:636‐9. - PubMed
Chahal 2008 {published data only (unpublished sought but not used)}
    1. Chahal K, Austin G, Empey DW, Chakravorty I. A pilot study of high frequency chest wall oscillation therapy in COPD with mucus hypersecretion [Abstract]. European Respiratory Society Annual Congress, Berlin, Germany, October 4‐8 2008:[P3337].
Chahal 2008a {published data only (unpublished sought but not used)}
    1. Chahal K, Austin G, Empey DW, Chakravorty I. High frequency chest wall oscillation for mucus clearance in COPD; a pilot study of exercise tolerance and health related quality of life [Abstract]. American Thoracic Society International Conference, May 16‐21, 2008, Toronto 2008:Poster #F102.
    1. Indranil C. Self administered high frequency oscillation technique for mucus clearance in COPD, an exploratory pilot project using SMARTVEST device. Hertfordshire Hospitals Research and Development Consortium 2006.
Christensen 1990b {published data only}
    1. Christensen EF, Nedergaard T, Dahl R. Long‐term treatment of chronic bronchitis with positive expiratory pressure mask and chest physiotherapy. Chest 1990; Vol. 97, issue 3:645‐50. - PubMed
Christensen 1991c {published data only}
    1. Christensen EF, Nedergaard T, Dahl R. Long‐term treatment of chronic bronchitis with pulmonary physiotherapy with and without positive expiratory pressure. Ugeskrift for Laeger 1991; Vol. 153, issue 2:113‐6. - PubMed
Conkic 1972 {published data only}
    1. Conkic B. The roll of physical therapy in the treatment of chronic bronchitis. Praxis der Pneumologie Vereinigt mit der Tuberkulosearzt 1972; Vol. 26:248.
Craven 1974 {published data only}
    1. Craven JL, Evans GA, Davenport PJ, Williams RH. The evaluation of the incentive spirometer in the management of postoperative pulmonary complications. British Journal of Surgery 1974; Vol. 61, issue 10:793‐7. - PubMed
Cross 2010 {published data only}
    1. Cross J. A single blind randomised controlled trial to determine the effectiveness and cost utility of manual chest physiotherapy techniques in the management of exacerbations of chronic obstructive pulmonary disease (MATREX). Suffolk and Norfolk Research and Development Consortium (S.A.N.D.) 2006. - PubMed
    1. Cross J. A single blind randomised controlled trial to determine the effectiveness and cost utility of manual chest physiotherapy techniques in the management of infective exacerbations of chronic obstructive pulmonary disease. National Coordinating Centre for Health Technology Assessment (NCCHTA) 2004. - PubMed
    1. Cross J, Elender F, Barton G, Clark A, Shepstone L, Blyth A, et al. A randomised controlled equivalence trial to determine the effectiveness and cost‐utility of manual chest physiotherapy techniques in the management of exacerbations of chronic obstructive pulmonary disease (MATREX). Health Technology Assessment 2010; Vol. 14, issue 23:i‐175. - PubMed
    1. Frances E. A single blind randomised controlled trial to determine the effectiveness and cost utility of manual chest physiotherapy techniques in the management of infective exacerbations of chronic obstructive pulmonary disease (MATREX). East Norfolk and Waveney Research Consortium (Norfolk & Norwich UH/ Norwich PCT/James Paget/NWMHP) 2005.
    1. Martin RA. MATREX Study ‐ single blind RCT to determine effectiveness and cost utility of manual chest physiotherapy techniques in management of exacerbation of COPD. Aintree University Hospitals NHS Foundation Trust 2007.
de Mello 2009 {published data only}
    1. Mello Rieder M, Costa AD, Vieira SRR. Short‐term effects of positive expiratory airway pressure in patients being weaned from mechanical ventilation. Clinics (Sao Paulo, Brazil) 2009; Vol. 64, issue 5:403‐8. - PMC - PubMed
della Torre 1990 {published data only}
    1. della Torre M, Montagna T, Bassi MG, Bertone P, Bossaglia G, Brega S, et al. ELTGOL in the treatment of COPD patients. European Respiratory Journal. Supplement 1990; Vol. 3, issue Suppl 10:416S.
Diette 2004 {published data only}
    1. Diette GB, Rand CS, Wise RA, Thompson B, Merriman B. Feasibility of using a sham control device in clinical trials of high‐frequency chest wall obstruction (HFCWO) in COPD [Abstract]. American Thoracic Society 100th International Conference, May 21‐26, 2004, Orlando 2004:C47 Poster F92.
Elkins 2001 {published data only}
    1. Elkins M, Badr C, Ellis E. Body position affects cough and huff strength in COPD. Thoracic Society of Australia and New Zealand Annual Scientific Meeting 2001.
Elkins 2001a {published data only}
    1. Elkins MR, Badr C, Ellis ER. Effect of body position on cough & huff strength in COPD. American Journal of Respiratory and Critical Care Medicine 2001; Vol. 163, issue Suppl 5:A693.
Esteve 1996 {published data only}
    1. Esteve F, Blanc‐Gras N, Gallego J, Benchetrit G. The effects of breathing pattern training on ventilatory function in patients with COPD. Biofeedback and Self Regulation 1996; Vol. 21, issue 4:311‐21. - PubMed
Falk 1981 {published data only}
    1. Falk P, Eriksen AM, Kolliker K, Andersen JB. Exercise and the breathless bronchitic. Lancet 1981; Vol. 1, issue 8210:54‐5. - PubMed
Gallon 1991 {published data only}
    1. Gallon A. Evaluation of chest percussion in the treatment of patients with copious sputum production. Respiratory Medicine 1991; Vol. 85, issue 1:45‐51. - PubMed
George 1985 {published data only}
    1. George RJ, Winter RJ, Flockton SJ, Geddes DM. Ventilatory saving by external chest wall compression or oral high‐frequency oscillation in normal subjects and those with chronic airflow obstruction. Clinical Science 1985; Vol. 69, issue 3:349‐59. - PubMed
Gervasini 1983 {published data only}
    1. Gervasini A, Satta A. Traditional respiratory physiotherapy in patients with chronic obstructive lung disease. Europa Medico Physica 1983; Vol. 19, issue 4:237‐44.
Guell 2000 {published data only}
    1. Guell R, Casan P, Belda J, Sangenis M, Morante F, Guyatt GH, et al. Long‐term effects of outpatient rehabilitation of COPD: a randomized trial. Chest 2000; Vol. 117, issue 4:976‐83. - PubMed
Hasani 1994 {published data only}
    1. Hasani A, Pavia D, Agnew JE, Clarke SW. Regional lung clearance during cough and forced expiration technique (FET): effects of flow and viscoelasticity. Thorax 1994; Vol. 49, issue 6:557‐61. - PMC - PubMed
He 1988 {published data only}
    1. He YZ. Medical gymnastics for chronic bronchitis,emphysema or early cor pulmonale during. Chinese Journal of Physical Therapy 1988; Vol. 11, issue 4:207‐8.
Herala 1995 {published data only}
    1. Herala M, Stalenheim G, Boman G. Effects of positive expiratory pressure (PEP), continuous positive airway pressure (CPAP) and hyperventilation in COPD patients with chronic hypercapnea. Upsala Journal of Medical Sciences 1995; Vol. 100, issue 3:223‐32. - PubMed
Ho 2000 {published data only}
    1. Ho SC, Chiang LL, Cheng HF, Lin HC, Sheng DF, Kuo HP. The effect of incentive spirometry on chest expansion and breathing work in patients with chronic obstructive airway diseases: comparison of two methods. Chang Gung Medical Journal 2000; Vol. 23, issue 2:73‐9. - PubMed
Kaminska 1988 {published data only}
    1. Kaminska TM, Pearson SB. A comparison of postural drainage and positive expiratory pressure in the domiciliary management of patients with chronic bronchial sepsis. Physiotherapy 1988; Vol. 74, issue 5:251‐4.
Krishnan 2009 {published data only (unpublished sought but not used)}
    1. Krishnan J, Ridge A, Walker Harris V, Lewis S, Ivy K, Dalapathi V. Treating exacerbations of asthma or chronic obstructive pulmonary disease (COPD) with high frequency chest wall oscillation (HFCWO) in hospitalized patients [Abstract]. European Respiratory Society Annual Congress, Barcelona, Spain, September 18‐22. 2010:[3869].
    1. Krishnan JA. Chest wall oscillation for asthma and COPD exacerbations trial (COAT). http://www.clinicaltrials.gov 2005.
    1. Krishnan JA, Ridge A, Harris VW, Lewis S, Ivy K, Dalapathi V, et al. Early treatment of acute asthma or chronic obstructive pulmonary disease (COPD) with high frequency chest wall oscillation (HFCWO) in hospitalized patients. Chest 2009; Vol. 136, issue 4:96S‐c, 97.
Kurabayashi 1998 {published data only}
    1. Kurabayashi H, Machida I, Handa H, Akiba T, Kubota K. Comparison of three protocols for breathing exercises during immersion in 38 degrees C water for chronic obstructive pulmonary disease. American Journal of Physical Medicine and Rehabilitation 1998; Vol. 77, issue 2:145‐8. - PubMed
Kurabayashi 2000 {published data only}
    1. Kurabayashi H, Machida I, Tamura K, Iwai F, Tamura J, Kubota K. Breathing out into water during subtotal immersion: a therapy for chronic pulmonary emphysema. American Journal of Physical Medicine and Rehabilitation 2000; Vol. 79, issue 2:150‐3. - PubMed
Lewczuk 1998 {published data only}
    1. Lewczuk J, Piszko P, Kowalska‐Superlak M, Jagas J, Wojciak S, Wrabec K. The impact of 2‐year rehabilitation on exercise tolerance and transcutaneous oxygen saturation during exercise in patients with chronic obstructive pulmonary disease [Polish] [Wplyw 2‐letniej rehabilitacji na tolerance wysilku i wysycenie tlenem krwi tetniczej w czasie wysilku u chorych na przewlekla obturacyjna chorobe pluc]. Polskie Archiwum Medycyny Wewnetrznej 1998; Vol. 100, issue 4:331‐6. - PubMed
Marcq 1975 {published data only}
    1. Marcq M, Frans A, Stanescu D, et al. Practical problems in the rehabilitation of coal‐miners with chronic bronchitis at the first stage of respiratory insufficiency. Rehabilitation (London) 1975; Vol. 92:23‐33.
Marcq 1981 {published data only}
    1. Marcq M, Minette A. Fonction cardio‐respiratoire de bronchitiques jeunes, pour la plupart mineurs de charbon, avant et apres kinesitherapie et entrainement a l‚effort. Comparaison avec un groupe temoin (resultats preliminaires). Revue de l'Institut d'Hygiene des Mines 1981; Vol. 36, issue 1:18‐31.
Marrara 2008 {published data only}
    1. Marrara KT, Marino DM, Held PA, Oliveira Junior AD, Jamami M, Lorenzo VAP. Different physical therapy interventions on daily physical activities in chronic obstructive pulmonary disease. Respiratory Medicine 2008; Vol. 102, issue 4:505‐11. - PubMed
McCarroll 2005 {published data only}
    1. McCarroll ML. The effects of exercise and airway clearing devices on chronic pulmonary diseased patients in pulmonary rehabilitation [Dissertation]. Ohio State University, 2005:96p.
McNeill 1955 {published data only}
    1. McNeill RS, McKenzie JM. An assessment of the value of breathing exercises in chronic bronchitis and asthma. Thorax 1955; Vol. 10, issue 3:651‐6. - PMC - PubMed
Mohsenifar 1985 {published data only}
    1. Mohsenifar Z, Rosenberg N, Goldberg HS, Koerner SK. Mechanical vibration and conventional chest physiotherapy in outpatients with stable chronic obstructive lung disease. Chest 1985; Vol. 87, issue 4:483‐5. - PubMed
Moiz 2006 {published data only}
    1. Moiz JA, Kishore K, Belsare DR. A comparison of autogenic drainage and the active cycle of breathing techniques in patients with acute exacerbation of chronic obstructive pulmonary disease. Indian Journal of Physiotherapy and Occupational Therapy 2006:10‐2.
Muzembo 2001 {published data only}
    1. Muzembo Ndundu J, Nkakudulu Bikuku H, Frans A. Respiratory rehabilitation in patients with bronchial asthma and chronic obstructive pulmonary disease (COPD) in Kinshasa. Revue de Pneumologie Clinique 2001; Vol. 57, issue 3:209‐18. - PubMed
Nakayama 1998 {published data only}
    1. Nakayama H, Shibuya M, Yamada SH, Arakawa M, Homma I. In‐phase chest wall vibration decreases dyspnea during arm elevation in chronic obstructive pulmonary disease patients. Internal Medicine 1998; Vol. 37, issue 10:831‐5. - PubMed
Nava 2006 {published data only}
    1. Nava S, Barbarito N, Piaggi G, Mattia E, Cirio S. Physiological response to intrapulmonary percussive ventilation in stable COPD patients. Respiratory Medicine 2006; Vol. 100, issue 9:1526‐33. - PubMed
Nosworthy 1992 {published data only}
    1. Nosworthy J, Barter C, Thomas S, Flynn M. An evaluation of three elements of pulmonary rehabilitation. Australian Journal of Physiotherapy 1992; Vol. 38, issue 3:189‐93. - PubMed
Olseni 1994 {published data only}
    1. Olseni L, Midgren B, Hornblad Y, Wollmer P. Chest physiotherapy in chronic obstructive pulmonary disease: forced expiratory technique combined with either postural drainage or positive expiratory pressure breathing. Respiratory Medicine 1994; Vol. 88, issue 6:435‐40. - PubMed
Padkao 2010 {published data only}
    1. Padkao T, Boonsawat W, Jones CU. Conical‐PEP is safe, reduces lung hyperinflation and contributes to improved exercise endurance in patients with COPD: a randomised cross‐over trial. Journal of Physiotherapy 2010; Vol. 56, issue 1:33‐9. - PubMed
Petersen 1967 {published data only}
    1. Petersen ES, Esmann V, Honcke P, Munkner C. A controlled study of the effect of treatment on chronic bronchitis. An evaluation using pulmonary function tests. Acta Medica Scandinavica 1967; Vol. 182, issue 3:293‐305. - PubMed
Salhi 2011 {published data only}
    1. Salhi B, Meerbeeck J, Joos GF, Derom E. Effects of whole body vibration in patients with COPD: a randomized study [Abstract]. American Journal of Respiratory and Critical Care Medicine 2011;183:A3968.
Saski 2005 {published data only}
    1. Saski T, Ebihara S, Yasuda H, Yamaya M. Effect of combination of mechanical insufflation‐exsufflation and flutter for sputum removal in elderly patients with dyspnea [Abstract]. American Thoracic Society 2005 International Conference; May 20‐25; San Diego, California 2005:[B52] [Poster: F96].
Saunders 1965 {published data only}
    1. Saunders KB, White JE. Controlled trial of breathing exercises. British Medical Journal 1965; Vol. 5463:680‐2. - PMC - PubMed
Savci 2000 {published data only}
    1. Savci S, Ince DI, Arikan H. A comparison of autogenic drainage and the active cycle of breathing techniques in patients with chronic obstructive pulmonary diseases. Journal of Cardiopulmonary Rehabilitation 2000; Vol. 20, issue 1:37‐43. - PubMed
Sergi 1990 {published data only}
    1. Sergi M, Forleo MV, Rizzi M. Chest physiotherapy in cold and long‐term oxygen therapy (LTOT) [abstract]. European Respiratory Journal. Supplement 1990; Vol. 3, issue Suppl 10:413S.
Shen 2008 {published data only}
    1. Shen ZK. Therapeutic effect observation of bailing capsule and medical gymnastics to COPD in paracmasis. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China Journal of Chinese Materia Medica 2008; Vol. 33, issue 8:942‐4. - PubMed
Skaria 2008 {published data only}
    1. Skaria S, Arun AJ, Sethi J. Effect of positive expiratory pressure technique over forced expiratory technique on bronchial hygiene in patients with moderate chronic bronchitis. Indian Journal of Physiotherapy and Occupational Therapy 2008; Vol. 2, issue 3.
Soler 2006 {published data only}
    1. Soler JJ, Martinez‐Garcia MA, Roman P, Orero R, Terrazas S, Martinez‐Pechuan A. Effectiveness of a specific program for patients with chronic obstructive pulmonary disease and frequent exacerbations. Archivos de Bronconeumologia 2006; Vol. 42, issue 10:501‐8. - PubMed
Su 2007 {published data only}
    1. Su CL, Chiang LL, Chiang TY, Yu CT, Kuo HP, Lin HC. Domiciliary positive expiratory pressure improves pulmonary function and exercise capacity in patients with chronic obstructive pulmonary disease. Journal of the Formosan Medical Association 2007; Vol. 106, issue 3:204‐11. - PubMed
Sutton 1983 {published data only}
    1. Sutton PP, Parker RA, Webber BA, Newman SP, Garland N, Lopez Vidriero MT, et al. Assessment of the forced expiration technique, postural drainage and directed coughing in chest physiotherapy. European Journal Respiratory Diseases 1983; Vol. 64, issue 1:62‐8. - PubMed
Szczegielniak 2006 {published data only}
    1. Szczegielniak J, Luniewski J, Bogacz K, Sliwinski Z. The effects of complex respiration physiotherapy in patients with acute stages of COPD [Polish] [Efekty kompleksowej fizjoterapii oddechowej u chorych w zaostrzeniach pochp]. Medycyna Sportowa 2006; Vol. 165, issue 6:313‐6.
Thomas 1988 {published data only}
    1. Thomas SH, Langford JA, George RJ, Geddes DM. Aerosol deposition in the human lung: effect of high‐frequency oscillation on the deposition characteristics of an inhaled nebulized aerosol. Clinical Science 1988; Vol. 75, issue 5:535‐42. - PubMed
Toshima 1990 {published data only}
    1. Toshima MT, Kaplan RM, Ries AL. Experimental evaluation of rehabilitation in chronic obstructive pulmonary disease: short‐term effects on exercise endurance and health status. Health Psychology 1990; Vol. 9, issue 3:237‐52. - PubMed
van der Schans 1986 {published data only}
    1. Schans CP, Piers DA, Postma DS. Effect of manual percussion on tracheobronchial clearance in patients with chronic airflow obstruction and excessive tracheobronchial secretion. Thorax 1986; Vol. 41, issue 6:448‐52. - PMC - PubMed
Wollmer 1985 {published data only}
    1. Wollmer P, Ursing K, Midgren B, Eriksson L. Inefficiency of chest percussion in the physical therapy of chronic bronchitis. European Journal of Respiratory Diseases 1985; Vol. 66, issue 4:233‐9. - PubMed
Xu 2000 {published data only}
    1. Xu GH. Study on the rehabilitating effects of respiration qigong on the COPD patients [Chinese]. Nanfang Journal of Nursing 2000; Vol. 7:2‐4.
Zakerimoghadam 2006 {published data only}
    1. Zakerimoghadam M, Shaban M, Kazemnejad A, Tavasoli K. The effect of breathing exercises on fatigue level of COPD patients [Persian]. HAYAT: The Journal of Tehran Faculty of Nursing & Midwifery 2006; Vol. 12, issue 3:17‐25.
    1. Zakerimoghadam M, Tavasoli K, Nejad AK, Khoshkesht S. The effect of breathing exercises on the fatigue levels of patients with chronic obstructive pulmonary disease. Acta Medica Indonesiana 2011;43(1):29‐33. - PubMed

References to studies awaiting assessment

Cegla 2000b {published data only}
    1. Cegla UH, Harten A. The RC‐Cornet‐intensified bronchospasmolysis of ipratropiumbromid in COPD. Pneumologie 2000; Vol. 54, issue SH1:S22‐3.
Chakravorty 2011 {published data only}
    1. Chakravorty I, Fasakin C, Austin G, Timbury C, Basu C. Impact of mucociliary clearance with high frequency chest wall oscillation in acute exacerbation of COPD [Abstract]. American Journal of Respiratory and Critical Care Medicine 2011;183:A5047.
Diette 2009 {published data only (unpublished sought but not used)}
    1. Diette G, Bilderback A, Becker B, Kachel D, Wise R, Rand C. Adherence to high‐frequency chest wall oscillation (HFCWO) improves quality of life in COPD [Abstract]. European Respiratory Society Annual Congress, Vienna, Austria, September 12‐16 2009:[P2090].
Esquinas 2010 {published data only}
    1. Esquinas A, Folgad M, Serrano J. Effects of intrapulmonary percussive ventilation as complementary technique in noninvasive mechanical ventilation during exacerbations of COPD [Abstract]. Intensive Care Medicine 2010;36:S388.
Long 2001 {published data only (unpublished sought but not used)}
    1. Long C. The effects of manual chest percussion in patients with chronic obstructive pulmonary disease and bronchiectasis. National Research Register 2001 2001.
Qu 2009 Jul {published data only}
    1. Qu Y, Peng H, Chen P, Xiang X. Combination of chest physiotherapy and intermittent non‐invasive mechanical ventilation for chronic obstructive pulmonary disease patients with respiratory failure [Chinese]. Zhong Nan Da Xue Xue Bao Yi Xue Ban = Journal of Central South University. Medical Sciences 2009;34(7):655‐8. - PubMed
Timbury 2010 {published data only}
    1. Timbury C, Austin G, McGowan J, Basu C, Joshi V, Meek Detal. High frequency chest wall oscillation in acute exacerbation of COPD; a pilot study of feasibility for supported early discharge [Abstract]. European Respiratory Society Annual Congress, Barcelona, Spain, September 18‐22. 2010:[P4105].

Additional references

Bateman 1979
    1. Bateman JR, Newman SP, Daunt KM, Pavia D, Clarke SW. Regional lung clearance of excessive bronchial secretions during chest physiotherapy in patients with stable chronic airways obstruction. Lancet. 1979/02/10 1979; Vol. 1, issue 8111:294‐7. - PubMed
Bellone 2000
    1. Bellone A, Lascioli R, Raschi S, Guzzi L, Adone R. Chest physical therapy in patients with acute exacerbation of chronic bronchitis: effectiveness of three methods. Archives of Physical Medicine and Rehabilitation. 2000/05/12 2000; Vol. 81, issue 5:558‐60. - PubMed
Borg 1982
    1. Borg GA. Psychophysical bases of perceived exertion. Medicine and Science in Sports and Exercise. 1982/01/01 1982; Vol. 14, issue 5:377‐81. - PubMed
Burgel 2009
    1. Burgel PR, Nesme‐Meyer P, Chanez P, Caillaud D, Carre P, Perez T, et al. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest. 2008/11/20 2009; Vol. 135, issue 4:975‐82. - PubMed
Campbell 1975
    1. Campbell AH, O'Connell JM, Wilson F. The effect of chest physiotherapy upon the FEV1 in chronic bronchitis. Medical Journal of Australia. 1975/01/11 1975; Vol. 1, issue 2:33‐5. - PubMed
Clarke 1973
    1. Clarke SW, Cochrane GM, Webber B. Effects of sputum on pulmonary function. Thoracic Society. London, 1973; Vol. 28, issue 2:262. - PMC - PubMed
Deeks 2008
    1. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions, Version 5.0.1 (updated September 2008). The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org.
Ekberg‐Aronsson 2005
    1. Ekberg‐Aronsson M, Pehrsson K, Nilsson JA, Nilsson PM, Lofdahl CG. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respiratory Research. 2005/08/27 2005; Vol. 6:98. - PMC - PubMed
Fagevik Olsen 2009
    1. Fagevik Olsen M, Westerdahl E. Positive expiratory pressure in patients with chronic obstructive pulmonary disease‐‐a systematic review. Respiration. 2008/10/10 2009; Vol. 77, issue 1:110‐8. - PubMed
Garrard 1978
    1. Garrard CS, Shah M. The effects of expiratory positive airway pressure on functional residual capacity in normal subjects. Critical Care Medicine. 1978/09/01 1978; Vol. 6, issue 5:320‐2. [0090‐3493: (Print)] - PubMed
Higgins 2008
    1. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, Available from www.cochrane‐handbook.org, 2008.
Hill 2009
    1. Hill K, Patman S, Brooks D. Effect of airway clearance techniques in patients experiencing an acute exacerbation of chronic obstructive pulmonary disease: a systematic review. Chronic Respiratory Disease. 2009/10/13 2009; Vol. 7, issue 1:9‐17. - PubMed
Holland 2006
    1. Holland AE, Button BM. Is there a role for airway clearance techniques in chronic obstructive pulmonary disease?. Chronic Respiratory Disease. 2006/05/30 2006; Vol. 3, issue 2:83‐91. - PubMed
Hurst 2009
    1. Hurst JR, Donaldson GC, Quint JK, Goldring JJ, Baghai‐Ravary R, Wedzicha JA. Temporal clustering of exacerbations in chronic obstructive pulmonary disease. American Journal of Respiratory Critical Care Medicine. 2008/12/17 2009; Vol. 179, issue 5:369‐74. - PubMed
Jones 1991
    1. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respiratory Medicine. 1991/09/01 1991; Vol. 85, issue Suppl B:25‐31; discussion 33‐7. - PubMed
Jones 1998
    1. Jones AP, Rowe BH. Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis. Cochrane Database of Systematic Reviews 1998, Issue 4. [DOI: 10.1002/14651858.CD000045] - DOI - PubMed
Kim 1987
    1. Kim CS, Iglesias AJ, Sackner MA. Mucus clearance by two‐phase gas‐liquid flow mechanism: asymmetric periodic flow model. Journal of Applied Physiology. 1987/03/01 1987; Vol. 62, issue 3:959‐71. - PubMed
Lange 1990
    1. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax. 1990/08/01 1990; Vol. 45, issue 8:579‐85. - PMC - PubMed
Martinez‐Garcia 2011
    1. Martinez‐Garcia MA, Soler‐Cataluna JJ, Donat‐Sanz Y, Catalan‐Serra P, Agramunt‐Lerma M, Ballestin‐Vicente J, et al. Factors associated with bronchiectasis in chronic obstructive pulmonary disease patients. Chest 2011;140(5):1130‐7. - PubMed
Oberwaldner 1986
    1. Oberwaldner B, Evans JC, Zach MS. Forced expirations against a variable resistance: a new chest physiotherapy method in cystic fibrosis. Pediatric Pulmonology. 1986/11/01 1986; Vol. 2, issue 6:358‐67. - PubMed
Patel 2004
    1. Patel IS, Vlahos I, Wilkinson TM, Lloyd‐Owen SJ, Donaldson GC, Wilks M, et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 2004/05/08 2004; Vol. 170, issue 4:400‐7. - PubMed
Prescott 1995
    1. Prescott E, Lange P, Vestbo J. Chronic mucus hypersecretion in COPD and death from pulmonary infection. European Respiratory Journal. 1995/08/01 1995; Vol. 8, issue 8:1333‐8. - PubMed
Rabe 2007
    1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine. 2007/05/18 2007; Vol. 176, issue 6:532‐55. - PubMed
RevMan 5 [Computer program]
    1. The Nordic Cochrane Centre: The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre: The Cochrane Collaboration, 2008.
Solway 2002
    1. Solway S, Brooks D, Lau L, Goldstein R. The short‐term effect of a rollator on functional exercise capacity among individuals with severe COPD. Chest. 2002/07/13 2002; Vol. 122, issue 1:56‐65. [0012‐3692: (Print)] - PubMed
Tang 2010
    1. Tang CY, Taylor NF, Blackstock FC. Chest physiotherapy for patients admitted to hospital with an acute exacerbation of chronic obstructive pulmonary disease (COPD): a systematic review. Physiotherapy. 2010/02/02 2010; Vol. 96, issue 1:1‐13. - PubMed
van der Schans 2000
    1. Schans Cees P, Prasad A, Main E. Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis. Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: 10.1002/14651858.CD001401] - DOI - PubMed
World Health Organization 2008
    1. World Health Organization. The global burden of disease: 2004 update. Available from http://whqlibdoc.who.int/publications/2008/9789241563710_eng.pdf. Geneva: WHO, 2008. [ISBN: 9789241563710]
Yankaskas 2004
    1. Yankaskas JR, Marshall BC, Sufian B, Simon RH, Rodman D. Cystic fibrosis adult care: consensus conference report. Chest. 2004/01/22 2004; Vol. 125, issue Suppl 1:1S‐39S. - PubMed

Publication types

MeSH terms